Quarterly report pursuant to Section 13 or 15(d)

STATEMENTS OF OPERATIONS

v3.24.1.1.u2
STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating expenses:    
Research and development $ 343,717 $ 497,714
General and administrative expenses 970,384 1,059,573
Total operating expenses 1,314,101 1,557,287
Loss from operations (1,314,101) (1,557,287)
Other income:    
Interest income 22,766 40,423
Total other income 22,766 40,423
Loss before income taxes (1,291,335) (1,516,864)
Net loss $ (1,291,335) $ (1,516,864)
Basic net loss per share (in dollars per share) $ (0.07) $ (0.08)
Diluted net loss per share (in dollars per share) $ (0.07) $ (0.08)
Weighted average number of shares outstanding - basic (in shares) 19,257,937 18,330,390
Weighted average number of shares outstanding - diluted (in shares) 19,257,937 18,330,390